Reinsurance Group of America, Incorporated · RZC · FY2026 Q1 · Calendar Q2 2026

RGA starts 2026 with broad earnings strength and disciplined capital deployment

The supplied analysis supports a constructive but qualified view: RGA entered 2026 with broad regional strength, favorable biometric claims experience and substantial excess capital. The case depends on disciplined deployment, sustained mortality experience and execution across financial solutions and longevity markets.

Reported Before market openNYSEFinancial Services $15.54B market cap
80quality score

Earnings scorecard

Reported versus consensus
Reported EPS Consensus —
EPS surprise Reported versus consensus
Reported revenue Consensus —
Revenue surprise Reported versus consensus

Market reaction

prior-close to event-session close
Stock move -0.1% Event window
SPY move -0.3% Same window
Abnormal move +0.2% Stock minus SPY
Volume 0.8× Versus trailing sessions
Subsequent drift +0.3% Up to 20 sessions
RZCSPY benchmark

Ask FN2 about RZC FY2026 Q1

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Relative to the prior-quarter analysis, the current analysis emphasizes a strong Q1 2026 start, $338 million of in-force investments, $50 million of share repurchases, $2.4 billion of excess capital and favorable biometric claims experience. It also notes no material in-force management actions during the quarter.

Guidance delta

Maintained; the supplied analysis reports no change to guidance.

Key takeaways

  • The supplied analysis describes strong Q1 2026 performance across regions, especially Asia Pacific and EMEA longevity.
  • RGA invested $338 million in in-force transactions and repurchased $50 million of shares.
  • Favorable biometric claims experience supported confidence in mortality assumptions.
  • Excess capital was reported at $2.4 billion, while the in-force pipeline remained healthy despite no material transactions this quarter.

Management priorities

  • Allocate $400 million of excess capital to reduce financial leverage in 2026.
  • Continue opportunistic share repurchases targeting 20-30% of after-tax earnings return.
  • Deploy remaining capital to Ruby Re and other block transactions.
  • Expand biometric and asset-linked solutions in Asia and the U.K. longevity market.

Follow RZC with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Company context

Snapshot as of publication

Reinsurance Group of America, Inc. functions as a holding company, concentrating on both conventional and cutting-edge life and health reinsurance offerings. Its operations are structured across five primary segments: the U.S. and Latin America, Canada, Europe, the Middle East and Africa (EMEA), Asia Pacific, and a distinct Corporate and Other division. The U.S. and Latin America segment is responsible for marketing individual and group life and health reinsurance to clients within its region, employing various agreement types such as yearly renewable term, coinsurance, and modified coinsurance.…

Historical context

All RZC earnings

Financial Services peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the RZC recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-05-17T18:08:43.183031+00:00
  2. FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
  3. Polygon adjusted daily market bars · 2026-09-24T12:40:56.158248+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-09-24. For educational purposes only; not investment advice.